Filing Details
- Accession Number:
- 0001062993-22-020022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-29 08:01:13
- Reporting Period:
- 2022-09-27
- Accepted Time:
- 2022-09-29 08:01:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1098880 | Intelgenx Technologies Corp. | IGXT | Pharmaceutical Preparations (2834) | 870638336 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649546 | Andre Godin | 255 Etienne-Lavoie, #1201 Laval A8 H7X 0E5 | President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, 0.00001 P.v. | Acquisiton | 2022-09-27 | 1,000 | $0.13 | 294,399 | No | 4 | P | Direct | |
Common Stock, 0.00001 P.v. | Acquisiton | 2022-09-28 | 9,000 | $0.14 | 303,399 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Note: Shares acquired on the TSX at C$0.18.
- Shares acquired on the TSX at C$0.185